ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CYDY CytoDyn Inc (QB)

0.1341
-0.0028 (-2.05%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 3,709,408
Bid Price 0.134
Ask Price 0.139
News -
Day High 0.142

Low
0.1275

52 Week Range

High
0.418

Day Low 0.1311
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0028 -2.05% 0.1341 17:20:00
Open Price Low Price High Price Close Price Prev Close
0.142 0.1311 0.142 0.1341 0.1369
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
292 3,709,408 $ 0.135916 $ 504,167 - 0.1275 - 0.418
Last Trade Time Type Quantity Stock Price Currency
16:00:00 4,314 $ 0.1341 USD

CytoDyn Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
127.34M 921.12M 556.02M 0 -79.82M -0.08 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CytoDyn (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CYDY Message Board. Create One! See More Posts on CYDY Message Board See More Message Board Posts

Historical CYDY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.15640.1640.13110.14205824,080,139-0.0223-14.26%
1 Month0.18290.3150.13110.18532974,896,387-0.0488-26.68%
3 Months0.16890.3150.12750.17544462,370,705-0.0348-20.60%
6 Months0.2270.35950.12750.18906242,926,427-0.0929-40.93%
1 Year0.2650.4180.12750.19669512,263,252-0.1309-49.40%
3 Years1.932.540.12750.5652562,203,128-1.80-93.05%
5 Years0.4510.010.12752.122,943,379-0.3159-70.20%

CytoDyn (QB) Description

CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions.

Your Recent History

Delayed Upgrade Clock